AlisonRaeMoliternoMD

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Moliterno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1989 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

225 citations
Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
Alison R. Moliterno, W D Hankins, Jerry L. Spivak
The New England Journal of Medicine. 1998-02-26
48 citations
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F
Brady L. Stein, Stephen T. Oh, Dmitriy Berenzon, Gabriela S. Hobbs, Marina Kremyanskaya
Journal of Clinical Oncology. 2015-08-31
34 citations
Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options
Brady L. Stein, Alison R. Moliterno, Ramon V. Tiu
Annals of Hematology. 2014-10-02

Abstracts/Posters

Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational Burden
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
ATM Germline Variant Increases the Risk of MPN Progression
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Independent Association of Male Sex with Presentation and Clinical Outcomes in Myeloproliferative Neoplasms
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans a...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018